Lupus Research Alliance News
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

  First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY. August 2, 2021. The Lupus Research Alliance (LRA) is particularly excited about the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (Saphnelo™), a first-in-class type I interferon receptor antagonist indicated for adults with […] READ MORE

COVID-19 Took Significant Toll on People with Lupus

July 29, 2021 A new study showed that people with lupus experienced significant physical and emotional effects in the early months of the COVID-19 pandemic.   Including LRA Scientific Advisory Board member Jane Salmon, MD, researchers at Hospital for Special Surgery and Tufts University in Boston invited 97 patients to complete a questionnaire in the […] READ MORE

LRA’s Visionary Strategy to Turn Lupus Complexity to its Cure

July 15, 2021 Dear Friends, With much excitement, we introduce our new overarching approach to fulfilling LRA’s mission: Turning Complexity to Cure. Our goal is to involve the lupus community and beyond in our strategy to turn the core problem of lupus – its heterogeneity – how much it differs from person to person – into its solution through […] READ MORE

Congress Continues Support for Lupus Research Program at $10 Million  

July 12, 2021 Today the House Appropriations Committee released the fiscal year 2022 Defense Appropriations Bill with $10 million for the Lupus Research Program (LRP) in the Congressionally Directed Medical Research Programs operated under the Defense Health Program. We are thankful that Congress maintained the funding for this program, and we remain committed to advocating for steady and robust investment for this critical […] READ MORE

Check Your Eyes for Healthy Vision Month

July 8, 2021 The Lupus Research Alliance is recognizing July’s designation as Healthy Vision Month by providing you with helpful information about its relevance to people with lupus from foremost authorities, the American College of Rheumatology and the American Academy of Ophthalmology. A medication commonly used to treat lupus inflammation, Plaquenil, can pose a risk to […] READ MORE

LRA Advocates Make the Difference

June 29, 2021 Today the House Appropriations Committee released the bill that funds the U.S. Food and Drug Administration (FDA). The bill’s accompanying report, which expresses Congressional intent for the use of the funding, includes this language regarding lupus drug development, which the Lupus Research Alliance advocated for along with our lupus patient advocates: Lupus […] READ MORE

Men and Lupus: What to Know

June 24, 2021 Men’s Health Month is the time to remind ourselves or the men in our lives to take stock of their physical and emotional wellbeing.  Paying attention to symptoms you might rather ignore is the intent behind recognizing this month. While 90% of people with lupus are female, 10% are males – the […] READ MORE

Learn and connect with our community!